Skip to main content

Table 3 Bivariate logistic regression model with odds of use of BB-CAM, adjusted for selected patients´ characteristics

From: Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

CHARACTERISTICS BB-CAM USE
Odds ratio 95% CI p
  Lower Upper  
Age (years)
 ≤60 yrs.   1.00 (Reference)    
 >60 yrs.   .612 .385 .972 .038
Therapy
 Bisphosphonates No medication 1.00 (Reference)    
Medication .975 .532 1.787 .934
 Antibodies No medication 1.00 (Reference)    
Medication .875 .503 1.521 .635
 Endocrine No medication 1.00 (Reference)    
Medication 1.018 .547 1.895 .955
 Chemotherapy No medication 1.00 (Reference)    
Medication 1.576 .879 2.824 .126
Therapy line .390
 Breast-Ca Neoadjuvant 1.00 (Reference)    
Adjuvant .766 .316 1.857  
Metastasis
1st -line
.394 .159 .973  
Metastasis
2nd -line
.823 .302 2.242  
Metastasis
3rd -line
1.649 .384 7.073  
Metastasis
≥4th -line
.948 .355 2.530  
Recurrence
1st -line
.892 .149 5.320  
Recurrence
≥2nd -line
.372 .054 2.544  
 Ovarian-Ca Adjuvant 1.072 .371 3.099  
Recurrent 1.035 .363 2.955